Business
DaVita Inc. 1st Quarter 2026 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026.
About this update from Davita Inc.
DENVER, May 5, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026. "DaVita's foundation is clinical excellence, driven by operating rigor that produces durable results," said Javier Rodriguez, CEO of DaVita Inc. "We have consistently delivered exceptional clinical outcomes and strong financial performance, and this quarter is no exception." Financial and operating highlights for the quarter and year ended March 31, 2026: U.S. dialysis metrics: Volume: Total U.S. dialysis treatments for the first quarter of 2026 were 7,029,525, or an average of 91,650 treatments per day, representing a per day increase of 0.05% compared to the fourth quarter of 2025. Normalized non-acquired treatment growth in the first quarter of 2026 compared to the first quarter of 2025 was 0.1%. Primary drivers of the changes in the table above were as follows: Revenue: The quarter change was primarily driven by the seasonal impact of co-insurance and deductibles and other normal fluctuations, partially offset by increases in average reimbursement rates, including Medicare base rate and other annual rate increases. The change from prior year quarter was driven by an increase in average reimbursement rates from normal annual increases, including Medicare base rate, and other normal fluctuations. Patient care costs: The quarter change was primarily due to increased compensation expenses and insurance costs, partially offset by decreased health benefits expense and pharmaceutical costs. The change from prior year quarter was primarily driven by increased compensation expenses, insurance costs and medical supplies expense. General and administrative: The quarter change was primarily due to decreased professional fees and health benefits expense, partially offset by increased compensation expenses. The change from prior year quarter was primarily driven by increases in IT-related costs and compensation expenses. Certain items impacting the quarter: Share repurchases. During the three months ended March 31, 2026, we repurchased 3.0 million shares for $403 million, at an average price paid of $133.70 per share. Subsequent to March 31, 2026 through May 5, 2026, the Company has repurchased 2.0 million shares of our common stock for $302 million at an average price paid of ...